Optimizing therapy for stable heart failure
Part of Heart & circulation clinical trials.
This study looks at ways to improve heart failure care by optimizing treatment. If you have stable heart failure, this trial aims to fine-tune your medication and management to help you feel better and stay healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with heart failure and have symptoms that make daily activities a bit hard (NYHA class II or III).
- You are 18 years or older.
- Your heart failure medication is stable and follows current guidelines.
- You live independently, not in a nursing home or rehab center.
- You can understand and communicate in Dutch.
- You are expected to live more than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This study tests different treatments for heart failure, a condition where the heart doesn't pump blood as well as it should. It aims to find better ways to manage symptoms and improve quality of life for people who are hospitalized or living with heart failure at home.
This trial uses a national heart failure registry to see if a new way of monitoring treatment can help optimize therapy for people with heart failure and reduced ejection fraction (a weak heart pump). It may lead to better medication adjustments over time.
This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.
This study looks at how well patients with heart failure who have reduced pumping function do when they receive the standard recommended medications. It aims to see short-term improvements in heart function and symptoms.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
Hear when a new Heart Failure NYHA Class II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.